Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

515 ARTÍCULOS , VIENDO DEL 121 AL 135

Hypertension and cerebral blood flow in the development of Alzheimer's disease

Bachmann D, Saake A, Studer S, Buchmann A, Rauen K, Gruber E, Michels L, Nitsch RM, Hock C, Gietl A, Treyer V; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2024 Nov;20(11):7729-7744. doi: 10.1002/alz.14233. Epub 2024 Sep 10.

MicroRNAs: pioneering regulators in Alzheimer's disease pathogenesis, diagnosis, and therapy

Li YB, Fu Q, Guo M, Du Y, Chen Y, Cheng Y.

Transl Psychiatry. 2024 Sep 10;14(1):367. doi: 10.1038/s41398-024-03075-8.

The impact of empowerment theory-based health education on Alzheimer's disease informal caregivers: a randomized controlled trial

Liu X, Wang S, Wei L, Liu Y, Bian J, Wang S, Du X.

Front Public Health. 2024 Aug 27;12:1393823. doi: 10.3389/fpubh.2024.1393823. eCollection 2024.

Overview of ADNI MRI

Jack CR Jr, Arani A, Borowski BJ, Cash DM, Crawford K, Das SR, DeCarli C, Fletcher E, Fox NC, Gunter JL, Ittyerah R, Harvey DJ, Jahanshad N, Maillard P, Malone IB, Nir TM, Reid RI, Reyes DA, Schwarz CG, Senjem ML, Thomas DL, Thompson PM, Tosun D, Yushkevich PA, Ward CP, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2024 Oct;20(10):7350-7360. doi: 10.1002/alz.14166. Epub 2024 Sep 11.

TRanscranial AlterNating current stimulation FOR patients with mild Alzheimer's Disease (TRANSFORM-AD): a randomized controlled clinical trial

Tang Y, Xing Y, Sun L, Wang Z, Wang C, Yang K, Zhu W, Shi X, Xie B, Yin Y, Mi Y, Wei T, Tong R, Qiao Y, Yan S, Wei P, Yang Y, Shan Y, Zhang X, Jia J, Teipel SJ, Howard R, Lu J, Li C, Zhao G.

Alzheimers Res Ther. 2024 Sep 12;16(1):203. doi: 10.1186/s13195-024-01570-0.

Association of Resilience-Related Life Experiences on Variability on Age of Onset in Dominantly Inherited Alzheimer Disease

Son HJ, Kim JS, Bateman RJ, Kim S, Llibre-Guerra JJ, Day GS, Chhatwal JP, Berman SB, Schofield PR, Jucker M, Levin J, Lee JH, Perrin RJ, Morris JC, Cruchaga C, Hassenstab J, Salloway SP, Lee JH, Daniels A; Dominantly Inherited Alzheimer Network (DIAN).

Neurology. 2024 Oct 8;103(7):e209766. doi: 10.1212/WNL.0000000000209766. Epub 2024 Sep 13.

Virtual Reality Combined With Psychoeducation to Improve Emotional Well-Being in Informal Caregivers of Alzheimer's Disease Patients: Rationale and Study Design of a Randomized Controlled Trial

Festari C, Bonomini C, Rosini S, Gattuso M, Singh Solorzano C, Zanetti O, Corbo D, Agnelli G, Quattrini G, Ferrari C, Gasparotti R, Pievani M, Morganti F.

Int J Geriatr Psychiatry. 2024 Sep;39(9):e6145. doi: 10.1002/gps.6145.

Morphometry of medial temporal lobe subregions using high-resolution T2-weighted MRI in ADNI3: Why, how, and what's next?

Yushkevich PA, Ittyerah R, Li Y, Denning AE, Sadeghpour N, Lim S, McGrew E, Xie L, DeFlores R, Brown CA, Wisse LEM, Wolk DA, Das SR; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2024 Nov;20(11):8113-8128. doi: 10.1002/alz.14161. Epub 2024 Sep 16.

Alzheimer Disease: Treatment of Cognitive and Functional Symptoms

Jaqua EE, Tran MN, Hanna M.

Am Fam Physician. 2024 Sep;110(3):281-293.

Atomically dispersed single-atom catalysts (SACs) and enzymes (SAzymes): synthesis and application in Alzheimer's disease detection

Goel H, Rana I, Jain K, Ranjan KR, Mishra V.

J Mater Chem B. 2024 Oct 23;12(41):10466-10489. doi: 10.1039/d4tb01293c.

Integrating amyloid and tau imaging with proteomics and genomics in Alzheimer's disease

Vilkaite G, Vogel J, Mattsson-Carlgren N.

Cell Rep Med. 2024 Sep 17;5(9):101735. doi: 10.1016/j.xcrm.2024.101735.

AI-driven innovations in Alzheimer's disease: Integrating early diagnosis, personalized treatment, and prognostic modelling

Kale M, Wankhede N, Pawar R, Ballal S, Kumawat R, Goswami M, Khalid M, Taksande B, Upaganlawar A, Umekar M, Kopalli SR, Koppula S.

Ageing Res Rev. 2024 Nov;101:102497. doi: 10.1016/j.arr.2024.102497. Epub 2024 Sep 16.

Measuring clinically relevant change in apathy symptoms in ADMET and ADMET 2

Tumati S, Herrmann N, Perin J, Rosenberg PB, Lerner AJ, Mintzer J, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Shade D, Lanctôt KL.

Int Psychogeriatr. 2024 Dec;36(12):1232-1244. doi: 10.1017/S1041610224000711. Epub 2024 Sep 19.

Brain volume change following anti-amyloid β immunotherapy for Alzheimer's disease: amyloid-removal-related pseudo-atrophy

Belder CRS, Boche D, Nicoll JAR, Jaunmuktane Z, Zetterberg H, Schott JM, Barkhof F, Fox NC.

Lancet Neurol. 2024 Oct;23(10):1025-1034. doi: 10.1016/S1474-4422(24)00335-1.

Prescription of Nonpharmacologic Interventions in Memory Clinics: Data from the Clinical Pathway for Alzheimer's Disease in China (CPAD) Study

Cai X, Zhang Y, Shi C, Wong GHY, Luo H, Wang H.

J Am Med Dir Assoc. 2024 Dec;25(12):105273. doi: 10.1016/j.jamda.2024.105273. Epub 2024 Sep 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias